Evaluate is the trusted provider of commercial intelligence, including product sales and consensus forecasts to 2024, for commercial teams and their advisors within the global life science industry. We help our clients make intelligent, high value decisions through superior quality, timely, must-have data and insights, combined with personalised, expert client support. Our online subscription services cover the pharmaceutical, biotech and medtech sectors. Our Custom Services group delivers project based analytical and data services. EP Vantage, our independent, award-winning editorial team, offers data-driven, forward-looking news, commentary and analysis on a daily basis. For more information visit www.evaluategroup.com.
We hope you can attend our BIO panel session, "Has big pharma fixed its broken innovation model", on Monday, June 4, 2018 1:00 PM - 2:15 PM in Room 257AB, Level 2. Panel participants include industry leaders from Janssen, Innovayte, and FasterCures, and the session will be moderated by Lisa Urquhart, Editor of EP Vantage.